Finance

Beta
Lists
ITRMF:OTCMKTS
Iterum Therapeutics PLC
$0.035
0.00%
(0.00) 1D
Jun 18, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ITRMF...
Open
$0.04
High
$0.04
Low
$0.04
Mkt. cap
1.63M
Avg. vol.
108.77K
Volume
7.86K
52-wk high
$0.08
52-wk low
$0.00
EPS
-$0.75
Beta
3.75
Shares outstanding
52.84M
No. of employees
9
Open
$0.04
High
$0.04
Low
$0.04
Mkt. cap
1.63M
Avg. vol.
108.77K
Volume
7.86K
52-wk high
$0.08
52-wk low
$0.00
EPS
-$0.75
Beta
3.75
Shares outstanding
52.84M
No. of employees
9
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to ITRMF in the past 3 months
Hold
Buy
0
Hold
2
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for ITRMF in the last 3 months.
Highest
Current $0.04
(-100.00%)
Average
(-100.00%)
Lowest
(-100.00%)
News stories
From sources across the web
About Iterum Therapeutics PLC
CEOCorey N. Fishman
Employees9
Founded2015
Headquarters-
SectorPharmaceutical industry
Websiteiterumtx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Revenue
-
-
-
390.00K
Cost of goods sold
254.00K
342.00K
345.00K
20.00K
Cost of revenue
254.00K
342.00K
345.00K
20.00K
Research and development expenses
1.30M
591.00K
1.00M
1.26M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.12M
2.78M
4.18M
6.49M
Operating expense
3.42M
3.37M
5.18M
8.10M
Total operating expenses
3.67M
3.71M
5.53M
8.12M
Operating income
-3.67M
-3.71M
-5.53M
-7.73M
Other non operating income
-2.01M
-587.00K
-605.00K
-675.00K
EBT including unusual items
-6.56M
-4.83M
-6.45M
-8.85M
EBT excluding unusual items
-6.56M
-4.83M
-6.45M
-8.85M
Income tax expense
25.00K
60.00K
59.00K
132.00K
Effective tax rate
-0.38%
-1.24%
-0.91%
-1.49%
Other operating expenses
-
-
-
-
Net income
-6.58M
-4.89M
-6.51M
-8.98M
Net profit margin
-
-
-
-2,302.31%
Earnings per share
-0.12
-
-
-
Interest and investment income
-
152.00K
-
121.00K
Interest expense
-874.00K
-686.00K
-316.00K
-562.00K
Net interest expenses
-874.00K
-534.00K
-316.00K
-441.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.41M
-3.36M
-5.18M
-7.38M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer